CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
Hematologic Oncology Update · Apr 10, 2026 · 24:54
Hematologic Oncology Update · Apr 10, 2026 · 24:54
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.
Episodes: Hematologic Oncology Update
